Early Phase Clinical Trials
Capabilities
Pharmaron’s Clinical Pharmacology Center (CPC), located in Baltimore, Maryland, is a full-service Phase 1 clinical trials facility, housing 96 beds across 4 First-in-Human (FIH) and 2 radiolabel (14C-hADME) dosing suites. Quick study start-up and flexible scheduling ensure that Pharmaron can continuously meet sponsor timelines, with 100% recruitment, >99% retention rate for short-term studies, and >95% retention rate for studies lasting up to two years.
The experienced team, facility design and geographic location provide operational excellence that ensures precision and integrity for all studies, while five full-time experienced Principal Investigators (PIs) ensure availability, continuity, and expert clinical oversight.
Key areas of expertise include integrated First-In-Human (FIH) clinical studies, 14C human ADME studies, vaccine and infectious disease studies and ethnobridging.
Full-service study management for early phase clinical trials
Full-service study management ensures that Pharmaron can guide clients through the full process of clinical development including regulatory affairs, patient management, medical writing and monitoring, pharmacovigilance, and quantitative pharmacology.